WHX Kuala Lumpur Dispatches | 10-min Quick Test Becomes Star Attraction! Why Sentegix Booth Draws Constant Stream of Visitors?
updated time：2025-07-18
News & Events
The July heatwave in Kuala Lumpur was intense, yet it paled in comparison to the electrifying atmosphere at WHX & WHX Labs 2025! WHX & WHX Labs Kuala Lumpur 2025 (World Health Expo & Lab Innovation Show) stands as one of Southeast Asia's largest and most influential healthcare industry gatherings. As the region's premier medical and health exhibition, WHX brings together global industry leaders, medical institutions, and innovative enterprises, offering a world-class platform for exchange and collaboration.
GenDx made a grand appearance in the main exhibition hall and the Innovation Lab (WHX Labs) with its comprehensive, all-scenario rapid genetic testing solutions. Its booth has teemed with visitors day after day – healthcare professionals, distributors, and laboratory experts have flocked to the scene to witness the speed of genetic technology powered by Chinese ingenuity!
GenDx
GenDx's 10-Minute Portable Rapid Test System (GD-220/GE4) has captured significant attention from customers, highlighting the surging demand for on-site testing technology.
The key themes spotlighted at this exhibition—localization of molecular diagnostics, portability for primary care, and enhanced efficiency in tropical disease screening—sharply outline Southeast Asia’s urgent demand for highly adaptable, low-cost solutions. This urgency mirrors the current global trajectory of the healthcare industry.
In response to these needs, GenDx’s GENEYE® Isothermal Amplification Technology Platform delivers beyond expectations. It transcends merely meeting the basic requirements of "fast" and "accurate" by pioneering a new paradigm for on-site nucleic acid diagnostics: "10-minute on-site testing" + "zero-lab-dependency".
So how—exactly—does GENEYE® achieve this "beyond expectations" performance?
How Fast? What Does It Mean?
The assay delivers results within 10 minutes—dramatically faster than traditional methods requiring hours to days. For acute tropical infectious diseases like dengue and malaria, its core value lies in compressing the diagnostic window into the golden treatment window. This not only dramatically reduces the risk of severe progression but also accelerates clinical decision-making, enabling precise early medication administration to optimize patient outcomes. The technology precisely addresses the urgent need for immediate, high-efficiency pathogen diagnosis in emergencies, outbreaks, and resource-limited settings.
Zero-Lab-Dependency: How? Why Does It Matter?
Operational Simplicity:
No complex sample processing; closed system after loading (no uncapping required)
Minimal training needed for non-specialists, lowering technical barriers and boosting efficiency
Environmental Flexibility:
Eliminates need for sophisticated instruments or dedicated lab spaces
Portable design + contamination-resistant technology enables deployment in primary care settings
Transformative Impact:
Solves critical pain points: Lab shortages, limited expertise, and prolonged sample transfer delays
Extends diagnostic capabilities to the "last mile" of healthcare networks—previously inaccessible areas
Cost Control: How Is It Achieved?
Streamlined Workflow & Minimal Equipment:
Reduces initial investment and operational complexity
High-Stability Reagent Chemistry:
Minimizes reagent waste and recalibration needs
System-Wide Value:
Lowers the total cost of ownership (TCO) for molecular diagnostics while maintaining performance
Strategic Alignment:
Directly fulfills the global public health mandate—particularly in resource-constrained regions—for sustainable, affordable diagnostic solutions aligned with universal health coverage imperatives.
GenDx's GENEYE® platform—through its profound insight into and breakthrough implementation of the "fast, accurate, easy, affordable" paradigm—not only perfectly aligns with core regional demands but also consistently drives molecular diagnostics beyond laboratories into field settings where they're critically needed. With its high sensitivity and specificity, the platform delivers reliable foundations for medical decision-making, cementing its role as a major innovator in the global POCT arena.
In the Name of Speed, We Usher in a New Era of Democratized Genetic Testing.
This exhibition marks not merely a product showcase, but the beginning of deeper partnerships across Southeast Asia.
GenDx eagerly anticipates establishing long-term strategic collaborations with global healthcare institutions and industry leaders to jointly advance innovation in medical health.
At the event, we heard the market's call—and renewed our commitment to our mission:
*"To globalize 10-minute ERA™ rapid nucleic acid testing technology, tackle critical diagnostic challenges, and make genetic science an accessible guardian of public health!"*
